Shah NN, Ahn KW, Litovich C, et al. Is autologous transplant in relapsed DLBCL patients achieving only a PET(+) PR appropriate in the CAR T-cell era? Blood. 2021;137(10):1416-1423.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Errata
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667047/
https://www.ncbi.nlm.nih.gov/pubmed/34014287
http://dx.doi.org/10.1182/blood.2021011979
_version_ 1784614321832067072
collection PubMed
description
format Online
Article
Text
id pubmed-8667047
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-86670472021-12-16 Shah NN, Ahn KW, Litovich C, et al. Is autologous transplant in relapsed DLBCL patients achieving only a PET(+) PR appropriate in the CAR T-cell era? Blood. 2021;137(10):1416-1423. Blood Errata American Society of Hematology 2021-05-20 /pmc/articles/PMC8667047/ /pubmed/34014287 http://dx.doi.org/10.1182/blood.2021011979 Text en © 2021 by The American Society of Hematology This article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Errata
Shah NN, Ahn KW, Litovich C, et al. Is autologous transplant in relapsed DLBCL patients achieving only a PET(+) PR appropriate in the CAR T-cell era? Blood. 2021;137(10):1416-1423.
title Shah NN, Ahn KW, Litovich C, et al. Is autologous transplant in relapsed DLBCL patients achieving only a PET(+) PR appropriate in the CAR T-cell era? Blood. 2021;137(10):1416-1423.
title_full Shah NN, Ahn KW, Litovich C, et al. Is autologous transplant in relapsed DLBCL patients achieving only a PET(+) PR appropriate in the CAR T-cell era? Blood. 2021;137(10):1416-1423.
title_fullStr Shah NN, Ahn KW, Litovich C, et al. Is autologous transplant in relapsed DLBCL patients achieving only a PET(+) PR appropriate in the CAR T-cell era? Blood. 2021;137(10):1416-1423.
title_full_unstemmed Shah NN, Ahn KW, Litovich C, et al. Is autologous transplant in relapsed DLBCL patients achieving only a PET(+) PR appropriate in the CAR T-cell era? Blood. 2021;137(10):1416-1423.
title_short Shah NN, Ahn KW, Litovich C, et al. Is autologous transplant in relapsed DLBCL patients achieving only a PET(+) PR appropriate in the CAR T-cell era? Blood. 2021;137(10):1416-1423.
title_sort shah nn, ahn kw, litovich c, et al. is autologous transplant in relapsed dlbcl patients achieving only a pet(+) pr appropriate in the car t-cell era? blood. 2021;137(10):1416-1423.
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667047/
https://www.ncbi.nlm.nih.gov/pubmed/34014287
http://dx.doi.org/10.1182/blood.2021011979

Ejemplares similares